AGP Picks
View all

Florida Tech Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Florida Tech Today.

Press releases published on June 29, 2026

Relax in Comfort Celebrates Grand Opening at Brandon Exchange Mall, Bringing Decades of Wellness Excellence to Tampa Bay
Certiprof Reinforces Global Authority Through Its Continued Membership in the IT Certification Council (ITCC)
Certiprof Announces Advanced University Certification Programs to Boost Student Workforce Readiness
Certiprof Launches ‘Trusted Consulting Partner™’ Program to Drive AI-Era Credibility for Professional Services
CybrHawk Announces Enterprise AI Integration with Anthropic to Accelerate Autonomous Cyber Defense
Lightspeed Systems Announces Most Comprehensive Screen Time Reporting and Management Solution for Schools
Atlantic Employee Screening Launches AES QuickApp™ with Biometric Identity Verification
Vivi Helps Schools Modernize Classrooms Without Replacing Aging IFPs
FDA Approves Arcutis’ ZORYVE® (roflumilast) Cream 0.3% for the Treatment of Plaque Psoriasis in Children as Young as Age 2
Tilray Brands Strengthens Global Medical Cannabis Platform and Canadian Patient Access Through HelloMD Acquisition
Praxis Precision Medicines Announces Extension Period for Relutrigine for Treatment of SCN2A and SCN8A Developmental and Epileptic Encephalopathies
Beach Day API Launches Real-Time Beach and Ocean Data API for Developers
Silo Pharma Advances SPC-15 PTSD Therapeutic with Drug-Device Robustness Study Ahead of Planned FDA Type C Meeting Request
Genmab Announces Positive Phase 3 Results for Epcoritamab Plus Lenalidomide in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma, Demonstrating Statistically Significant Improvement in Progression-Free Survival
Dragon Pharma Store Announces Expansion of Research Product Catalog with Addition of KLOW 80mg
Digital Realty Announces Secondary Offering of Common Stock by Blackstone
Abivax Reports Positive ABTECT Maintenance Part 2 Results for Obefazimod, Demonstrating Meaningful Clinical Benefit in Refractory Ulcerative Colitis Patients and Strengthening the Phase 3 Maintenance Safety Database
Résultats positifs de la partie 2 de l’essai de maintenance ABTECT démontrant un bénéfice clinique significatif chez des patients atteints de RCH réfractaire et renforçant les données de sécurité
Gain Therapeutics Receives FDA Clearance of IND to Advance GT-02287 into Phase 2 Clinical Development for Parkinson’s Disease
Digital Realty Announces Purchase of Blackstone Interest in Three Northern Virginia Data Centers

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Florida Tech Today

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.